Dear BioFITers,

Get ready to have more VC insights!

Frank Hensel, Investment Manager at High-Tech Gründerfonds based in Germany will share his expertise in Track 2, dedicated to Key issues in licensing and tech transfer.

Mr. Hensel will discuss a topic dividing crowds :  „What is the best background for an academic spin-off CEO?“ . He will speak alongside Kai Simons, Director Emeritus of the Max Planck Institute CBG and now CEO of Lipotype. Mr Hensel and Mr Simons will be supplemented by a pharma representative and an HR expert, to form a very exciting panel!

Do you want to speak in this panel or join BioFIT speaker team? Contact Claire or Ramona, in charge of BioFIT 2016 conference programme.